Authors
Latest:
Unmet Needs in Management of C. Difficile Infection (CDI)Bincy Abraham, MD, MS; Thomas Lodise, PharmD, PhD; Teena Chopra, MD, MPH; and Paul Feuerstadt, MD, share unmet needs, including access to therapies, in treatment of C. difficile infection (CDI).
Latest:
Assessing Philadelphia-Like B-Cell ALL in a Largely Hispanic PopulationPh-like ALL may be predominantly prevalent in Hispanic and Latino populations.
Latest:
Half of Pharmacy Technicians Feel Fulfilled in Their Current RoleThe Connecticut Society of Health-System Pharmacists Technician Committee survey explores the perception of career growth opportunities and challenges.
Latest:
America Must Address the Pandemic of Health Care InequitiesBlack History Month provides a reminder of the systemic barriers facing many Americans
Latest:
Oncology Overview: Selpercatinib for RET-Positive Metastatic Non-Small Cell Lung CancerSelpercatinib is an oral selective RET kinase inhibitor approved for the treatment of metastatic RET fusion-positive non-small cell lung cancer and for metastatic thyroid cancer.
Latest:
Developing Relationships With State Boards of Pharmacy Is Valuable for Pharmacies and PharmacistsA pharmacy's relationship with its state board(s) of pharmacy is crucial for its operation and success, yet it is often overlooked due to the complex demands on pharmacists and pharmacy owners.
Latest:
Equal but Not the Same—2021 Update on Influenza VaccinesAs COVID-19 vaccination efforts continue, it is more important than ever for pharmacists to be equipped with the knowledge and resources to bust the myths surrounding vaccinations, particularly in preparation for the upcoming influenza season, which is expected to occur from October 2021 to May 2022.
Latest:
ABM Offers Opportunity for Professional GrowthAppointment-based models are typically most effective when all pharmacy team members participate.
Latest:
Pharmacists Can Make a Difference in Antibiotic Stewardship at DischargePharmacist-led discharge stewardship initiatives have shown promising results.
Latest:
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood CancerAdvances, challenges, and promising innovations emerge.
Latest:
AAN 2025: Intracerebral Hemorrhage Treatment Requires Proactive Approach, Pharmacist InvolvementKara Melmed, MD, emphasizes the critical importance of rapid, team-based intervention for intracerebral hemorrhage (ICH) patients, with pharmacists playing a key role in blood pressure management.
Latest:
Incorporation of Medication Synchronization in Community Pharmacy Workflow Enhances Delivery of Patient Care ServicesThe biggest advantage of med sync for a community pharmacy is the proactive selection of a date to have all the patient’s chronic medications filled simultaneously.
Latest:
Pharmacists Can Make a Difference in Antibiotic Stewardship at DischargePharmacist-led discharge stewardship initiatives have shown promising results.
Latest:
Overview of Nurtec ODT for Prevention of Episodic MigraineNurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.
Latest:
AI’s Shot in the Arm of Science and the Concerns We Need to AddressStakeholders need to convene honest, actionable discussions about the challenges and the safeguards needed to address appropriate use of artificial intelligence in health care.
Latest:
Understand Tofersen, the First FDA-Approved Drug Targeted to Slow Disease Progression in SOD1-Mutated ALSPharmacists play a key role in optimizing drug therapy according to the most updated guidelines, educating patients or prescribers, and monitoring therapeutic outcomes.
Latest:
Asembia AXS25: Patients Desire Education and Thorough Resources to Better Navigate Health PlansA panel of health care experts at Asembia’s AXS25 Summit discussed the critical need for improved patient education and resources to help navigate complex financial assistance programs and health care plans.
Latest:
Getting in the Mindset to Become a Successful Preceptor: How to Precept ResponsiblyStudents should prepare to be preceptors early in their pharmacy school careers.
Latest:
From Abemaciclib to Trastuzumab Deruxtecan: Highlights From the 2024 San Antonio Breast Cancer SymposiumExperts presented results that may transform treatment and clinical practice strategies.
Latest:
Unrecognized Costs Associated With Clostridium Difficile Infection: What HCPs Often MissFrom an economic perspective, C. difficile has a staggering financial impact on the US health care system, as well on the patients infected.
Latest:
The Pharmacist's Role in Prior AuthorizationsThe prior authorization process often involves complex transactions and increases the burden not only on physicians and pharmacies, but can also impact patient access.
Latest:
All Pharmacies Are Not the Same: Community Pharmacy QualityPatients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
Latest:
Advise Patients About OTC Options for Treating Motion SicknessMany cases of motion sickness can be managed safely with available OTC products.
Latest:
Leveraging Technology to Enhance Women’s Health and Access to CarePanelists discuss how digital health technologies revolutionize women’s health care through telehealth, mobile apps, and remote monitoring, expanding access, personalization, and proactive medical support.
Latest:
2023 Forecasts for Pharmacy Services, Medication Costs During the Rise of Personalized MedicineData from a recent survey reflect a resounding shift toward the role of pharmacies becoming sites for primary care.
Latest:
Empower Prospective Pharmacists through Children’s BooksThis short story, illustrated by Roth, portrays pharmacists in a variety of settings and was written with the intent to introduce the career in a fun and understandable way for children and inspire kids to pursue their dreams.
Latest:
Pharmacy Department-Driven Initiative to Reduce Subcutaneous Daratumumab Observation TimeObservation time on subsequent injections of subcutaneous daratumumab may be safely removed from institutional policies to reduce chair time.
